PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation

Immunotherapy has become a crucial modality for non-small-cell lung cancer treatment. Recently, two immune checkpoints, PD-1 and PD-L1, have emerged as important targets for immunotherapy. Their antitumor efficacy has been confirmed by in vitro and in vivo studies. But the correlation between PD-1/P...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Mei, Liu, Yan, Li, Qing, Li, Xiao-Dong, Zhao, Wei-Qing, Zhang, Hanze, Zhang, Xiaofei, Jiang, Jing-Ting, Wu, Chang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302082/
https://www.ncbi.nlm.nih.gov/pubmed/25592115
http://dx.doi.org/10.1186/s12967-014-0373-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302082/
https://www.ncbi.nlm.nih.gov/pubmed/25592115
http://dx.doi.org/10.1186/s12967-014-0373-0

Ejemplares similares